BACKGROUND: Liver transplantation is a complex surgery associated with high rates of postoperative complications. While national outcomes data are available, national rates of most complications are unknown.
postoperative complication rates can lead to outcome improvement and significant cost savings, as complications in liver transplant recipients are more costly than in other surgical populations. For example, pneumonia, which adds an estimated cost of $20,000 for a patient in the general intensive care unit, adds $100,000 additional cost in a liver transplant recipient. 2 In an effort to summarize the presently available data in the literature, we have performed a review of the clinical literature over the past 10 years to identify rates of the most frequently reported biliary, vascular, hemorrhagic and thrombotic, renal, pulmonary, infectious, gastrointestinal, and cardiac complications after liver transplantation.
Patients and Methods

Data sources
A review of the literature was performed to identify studies that reported the incidence of postoperative complications in deceased donor liver transplant recipients within the first year of surgery. Studies were identified through a search of MEDLINE on October 10, 2012, using the Medical Subject Headings ''liver transplantation,'' ''postoperative complications,'' ''myocardial infarction,'' ''pericardial effusion,'' ''anastomotic leak,'' ''renal failure,'' ''respiratory failure,'' ''pneumothorax,'' ''pulmonary edema,'' ''deep venous thrombosis,'' ''pulmonary embolus,'' ''pleural effusion,'' ''postoperative hemorrhage,'' ''cardiac arrest,'' ''arrhythmia,'' and ''intestinal obstruction'', which were chosen to reflect the most common postsurgical complications in transplant recipients. A manual search of publication bibliographies was also performed.
Study selection
Institutional review board approval was received before collection of any data. Articles were selected for inclusion if they reported an incidence of postoperative complications in deceased donor liver transplant recipients based on human adult studies over the past decade. Articles were excluded if they were not available in English, were published before January 1, 2002, or originated from a location other than the United States, Australia, Canada, and Europe. Articles focusing on complications related to children, living donor liver transplant, multivisceral, and retransplantation were excluded. Analysis of complications related to immunosuppression, post reperfusion syndrome, and malignancy were excluded. Care was taken to exclude initial reports if follow-up reports were available. Decision 
Data extraction and quality assessment
Data from the selected manuscripts were independently extracted from each study by 3 reviewers (L.M.M., A.D., A.E.D.). Discordant data were solved by a consensus among the investigators with guidance from a fourth reviewer (D.P.L.). Incidences of the following complications were extracted: biliary (leak, stricture), vascular (hepatic artery thrombosis, hepatic artery stenosis, portal vein thrombosis, portal vein stenosis), hemorrhagic and thrombotic (hemorrhage, deep vein thrombosis, pulmonary embolus), renal (acute renal failure, temporary dialysis, permanent dialysis), pulmonary (respiratory failure, pulmonary edema, pleural effusion, pneumothorax, hospitalacquired pneumonia), infectious (intra-abdominal abscess, peritonitis, sepsis, surgical site infections, bacteremia, urinary tract infections, cytomegalovirus, bacteria, viral, fungal, protozoal), gastrointestinal (bowel obstruction, incisional hernia, gastrointestinal bleed), and cardiac complications (myocardial infarction, pericardial effusion, cardiac arrest, arrhythmia).
Data synthesis and analysis
For each complication subgroup (biliary, vascular, hemorrhagic/thrombotic, renal, pulmonary, infectious, gastrointestinal, and cardiac), single group proportions were summarized using weighted averages of means and standard deviations for each study reporting the complication of interest. Incidence effect estimates were summarized using the DerSimonian and Laird random-effects model. 3 Incidence rates were calculated as percentages. Heterogeneity was assessed using the Cochran Q chi-square test and the I 2 statistic, and was considered significant if P less than .10 or if I 2 was 50% or greater. To explore the potential sources of heterogeneity, we performed additional subset analyses of studies from the United States.
Funnel plots and Egger's regression test were used to assess the potential risk of publication bias. Statistical analyses were performed using SAS 9.3 statistical software (SAS Institute, Cary, NC) and StatsDirect statistical software (StatsDirect Ltd, Altrincham, UK; http://www. statsdirect.com).
Results
Search results
A schematic of the search algorithm is shown in Fig. 1 . Our original search criteria returned 8,170 studies, 6,253 of which were eliminated based on application of our primary exclusion criteria (language, date, animal studies, pediatric studies, and geography) and title review. Abstract review was performed for 1,917 studies, 1,783 of which were removed. After supplemental search results were added, 134 studies were selected for full-text review. Overall, our meta-analysis includes 29,227 deceased donor liver transplant recipients from 74 studies performed between 2002 and 2012. Table 1 lists the characteristics of studies included in our final analysis. Of the studies retained, 26 reported on complications in the United States, 44 in Europe, 2 in Australia, and 4 in Canada; 6 included information on donation after cardiac death. Six had a prospective design.
Pooled proportions of complications. Table 2 lists the pooled proportions, heterogeneity, and publication bias for complications reported by 4 or more studies. Overall, the incidences of 14 complications were each reported by 5 or more studies. These complications were selected for full quantitative analysis with forest plots shown in Fig. 2 Hepatic artery thrombosis was reported by 13 studies, with a pooled incidence of .045 (95% CI: .031 to .062). Rates of hepatic artery stenosis were reported by 5 studies with a combined incidence of .045 (95% CI: .015 to .089). Rates of portal vein thrombosis were reported by 5 studies, with a combined incidence of .042 (95% CI: .021 to .070). Only 2 studies reported rates of portal vein stenosis, which were not included in our quantitative analysis.
Hemorrhagic and thrombotic complications: postoperative hemorrhage, deep venous thrombosis, and pulmonary embolus. Eight studies reported rates of hemorrhagic and thrombotic complications. 1, 10, 19, 21, 24, [35] [36] [37] [38] Of these, 5 studies reported rates of postoperative hemorrhage, with an estimated mean incidence of .083 (95% CI: .046 to .131). Four studies reported rates of pulmonary embolus, with a combined incidence of .012 (95% CI: .001 to .034). A single study reported rates of deep vein thrombosis, which was not included in our quantitative analysis.
Renal complications: acute renal failure with temporary and permanent need for hemodialysis. Fourteen studies reported rates of renal complications. [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] Thirteen studies reported rates of acute renal failure, with a pooled proportion of .299 (95% CI: .220 to .385). Three studies reported rates of acute renal failure with a temporary need for dialysis (pooled proportion .195; 95% CI: .063 to .377). Only 3 studies reported rates of permanent need for hemodialysis, which were not included in our quantitative analysis.
Pulmonary complications: respiratory failure, pulmonary edema, pleural effusion, pneumothorax, and pneumonia. Twelve studies reported rates of pulmonary complications. 1, 35, 38, 41, 50, [54] [55] [56] [57] [58] [59] [60] [61] [62] Eight studies reported rates of pneumonia, with a combined incidence of .115 (95% CI: .054 to .195). Five studies each reported rates of pulmonary edema (pooled proportion 5 .202; 95% CI: .064 to .391) and pleural effusion (combined incidence .379; 95% CI: .092 to .724). Not included in our quantitative analysis were 3 studies that reported rates of pneumothorax and 2 studies that reported rates of respiratory failure.
Infectious complications: intra-abdominal abscess, peritonitis, sepsis, surgical site infection, bacteremia, urinary tract infection, cytomegalovirus, bacterial, viral, fungal, protozoan. Twenty studies reported rates of infectious complications. 1, 11, 19, 21, 35, 58, [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] Five studies reported rates of intra-abdominal abscess, with a combined incidence of .044 (95% CI: .019 to .078). Six studies reported rates of surgical site infection (pooled proportion .118; 95% CI: .054 to .202). Bacteremia rates were reported by 6 studies, with a combined incidence of .142 (95% CI: .072 to .231). Four studies reported rates of viral infections (pooled proportion .128; 95% CI: .028 to .284) and fungal infections (pooled proportion .147; 95% CI: .119 to .176) without specific organism or system involvement. Peritonitis, sepsis, urinary tract infection, cytomegalovirus, bacterial, and protozoan infections were each reported by less than 3 studies.
Gastrointestinal complications: bowel obstruction, incisional hernia, gastrointestinal bleed. Gastrointestinal complications were reported in 6 studies. 1, 71, [77] [78] [79] [80] [81] [82] Incisional hernia was reported in 5 studies, with a pooled proportion of .084 (95% CI: .049 to .127). Gastrointestinal bleed and bowel obstruction were reported in an insufficient number of studies for quantitative analysis.
Cardiac complications: myocardial infarction, cardiac arrest, pericardial effusion, and arrhythmia. Cardiac complications were reported in 4 studies.
1,57,61,83 Rates of myocardial infarction, cardiac arrest, pericardial effusion, and arrhythmia were reported in an insufficient number of studies for quantitative analysis.
Comments
Postoperative morbidity after liver transplant is due to a combination of factors related to the patient polymorbidity, graft quality, surgical procedure, and postoperative management. Our analysis is the first to report on the pooled incidence rate of the 17 most frequent postoperative complications following deceased donor liver transplant. Our pooled complication rates are lower than those reported previously in the literature, likely demonstrating advancements in both surgical technique and patient care. Pooled complication rates after liver transplantation are very important, as they provide data beyond single center information and transplant clinician perception. They also provide a resource for setting the expectations of providers, patients, and families as part of preoperative informed consent process.
Our review allows centers to distinguish between those complications which might be related to surgical technique and which may be reducible through improvements in patient care. Among the discussed complications, biliary leak and stricture, hepatic artery thrombosis, hepatic artery stenosis, portal vein thrombosis, pleural effusion, intra-abdominal abscess, and incisional hernias are commonly believed to be associated with the surgical procedure or surgical technique. Some may be preventable, while others are likely not. In contrast, some of the complications might be mitigated by improvement of the overall care to the liver transplant recipients. For example, the 1.2% complication rate of pulmonary embolus would indicate a significantly higher incidence of deep vein thrombosis, which is known to be reducible with patient care efforts such as diligent placement of sequential compression devices and initiation of heparin once the liver function (eg, international normalized ratio) has normalized. 84 Similarly, it is likely that the postoperative pneumonia rate of 15% can be reduced by systematic and intensive pulmonary rehabilitation, such as chest physical therapy, incentive spirometry, early ambulation, short intubation times, and other focused interventions, described in general surgery patients. 85 Interestingly, the magnitude of the different pooled complication cohorts seems to also reflect the difference in perceived preventability by the transplant community. While biliary complications and infections have large pooled cohorts, pulmonary complications are noticeably smaller. This is most likely because of the fact that biliary complications are deemed preventable, while pleural effusion, for example, is deemed a nonpreventable complication directly related to the loss of peritoneal coverage of the diaphragm because of hepatectomy. The transplant community has been at the forefront of transparency and quality improvement, and research efforts continue attempts to minimize postoperative morbidity in these incredibly challenging and complex patients. While patient and graft survival is collected rigorously by the United Network for Organ Sharing, there is currently no systematic collection of data on postoperative complications for transplant patients. A national registry of major complications would improve the ability to provide patients with informed consent, serve as a tool for individual center performance monitoring, and provide a central source against which to measure interventions aimed at improving patient care. Successful examples of such registries include the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and the National Heart, Lung, and Blood Institute Dynamic Registry. 86 The American College of Surgeons National Surgical Quality Improvement Program (NSQIP) collects and reports postoperative complication rates for many surgical specialties, but currently not for transplant. As complication rates in transplant recipients cannot easily be compared with other patient populations because of the polymorbid nature of end-stage organ disease, adding transplant patients to this national data collection effort would allow for individual center and physician feedback, and is likely to provide information that can lead to outcome improvement. Allowing for comparison of centers with the national mean, if appropriately adjusted, might provide focused incentive to improve outcomes where possible in a field where clinicians are extremely motivated to obtain optimal outcomes for their sick patients. Only reliable, consistently collected data will allow for effectively targeted efforts toward preventing complications. This will require uniformly trained personnel and voluntary participation by centers. The American Society of Transplant Surgeons is presently considering in participating in National Surgical Quality Improvement Program for this reason.
A limitation of this study is the heterogeneity between the studies performed. This may be in part because of variation in sample size. The majority of studies included in our review examined less than 1,000 patients, and 6 studies examined between 1,000 and 2,000 patients. Subgroup analysis of studies performed in the United States was conducted to assess for the relationship of different national systems of quality regulation. We found little difference in the results to account for this variability. We also performed subgroup analysis of donation after cardiac death donors, but again, found no significant difference in rates. In the end, rather than search for an absolute value of these complications, perhaps we should accept that the range is wide and influenced by not only system-level factors but also hospital-level factors. This too is a reason to prospectively collect center-specific data on postoperative complications after liver transplantation.
In summary, this is the first systematic review of the incidence of the major postoperative complications after liver transplantation, providing an important reference for healthcare providers and patients. Prospective national collection of complications in the form of a registry may offer opportunities to improve outcomes for these very sick patients undergoing a highly complex, but lifesaving operation.
